
Janus Henderson Investors
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Janus Henderson Investors is an asset manager that helps their clients achieve their financial goals.
Investor Profile
Janus Henderson Investors has backed more than 168 startups, with 19 new investments in the last 12 months alone. The firm has led 16 rounds, about 10% of its total and boasts 97 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 2 rounds in the past year.
Stage Focus
- Series B (30%)
- Post Ipo Equity (29%)
- Series C (17%)
- Series A (12%)
- Series D (6%)
- Series Unknown (2%)
- Private Equity (1%)
- Series E (1%)
- Series F (1%)
- Series G (1%)
Country Focus
- United States (88%)
- Canada (3%)
- United Kingdom (2%)
- China (2%)
- Singapore (1%)
- Denmark (1%)
- The Netherlands (1%)
- Spain (1%)
- India (1%)
- Germany (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Life Science
- Biopharma
- Oncology
- Health Diagnostics
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.